News

Healio12h
FDA’s plan to phase out animal testing could accelerate approval of new sunscreens in US
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
Pharmabiz19h
Atsena Therapeutics receives US FDA’s RMAT designation for ATSN-201 gene therapy to treat X-linked Retinoschisis
Durham, North Carolina Thursday, April 17, 2025, 12:00 Hrs [IST] ...